Breast cancer immunophenotypes and serum organochlorine pesticides in Mexican women: Mixture exposure approach

被引:0
作者
Ugalde-Resano, Rodrigo [1 ]
Merida-Ortega, Angel [1 ]
Cebrian, Mariano E. [2 ]
Lopez-Carrillo, Lizbeth [1 ]
机构
[1] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Ave Univ 655, Santa Maria 62100, Morelos, Mexico
[2] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Toxicol, Ave Inst Politecn Nacl 2508, Mexico City 07360, Mexico
关键词
Organochlorine pesticides; Mixture analysis; Breast cancer; Immunophenotypes; BETA-HEXACHLOROCYCLOHEXANE; POLYCHLORINATED-BIPHENYLS; RECEPTOR ACTIVITIES; RISK; METAANALYSIS; ESTROGEN; ASSAYS;
D O I
10.1016/j.envpol.2024.124495
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Epidemiological studies on associations between breast cancer (BC) and organochlorine pesticides (OCP) are inconclusive. The majority of studies have evaluated the effect of single compounds without considering multiple OCP exposures and immunophenotypes of BC. We aimed to evaluate the association between BC immunophenotypes and serum OCP mixtures, and identify the main contributors within mixtures. We included 767 histopathologically confirmed incident BC cases and 908 controls from a population-based case-control study conducted from 2007 to 2011 in Northern Mexico. We obtained direct information about sociodemographic, lifestyle and reproductive characteristics. We collected data from clinical records about hormonal receptors (HR) and epidermal growth factor receptor 2 (HER2) expressions. Immunophenotypes were determined as HR+/ HER2-, HER2+ or HR-/HER2-. We quantified OCP and metabolites by gas chromatography using an electron capture micro detector. We used Weighted Quantile Sum regression to assess the association of BC and exposure to multiple OCP, and their contribution within the mixture. We found a positive adjusted association between BC and an OCP mixture (OR: 3.48, 95%CI: 2.58, 4.69), whose primary contribution arose from the isomers of hexachlorocyclohexane and endosulfan, as well as endosulfan sulfate. We also identified a mixture negatively associated (OR: 0.13, 95%CI: 0.08, 0.20), characterized by p,p'-DDT and chlordane metabolites. All these associations remained regardless BC immunophenotypes. This is the first epidemiological report that identified serum OCP mixtures associated with BC immunophenotypes. Due to OCP ubiquity, biomagnification, and continuous exposure, they constitute a global problem of persistent exposure that might be related to BC risk.
引用
收藏
页数:9
相关论文
共 62 条
  • [61] Pharmacokinetic variability and modern epidemiology - The example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort
    Wolff, Mary S.
    Anderson, Henry A.
    Britton, Julie A.
    Rothman, Nat
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (10) : 1925 - 1930
  • [62] Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
    Yang, Xiaohong R.
    Chang-Claude, Jenny
    Goode, Ellen L.
    Couch, Fergus J.
    Nevanlinna, Heli
    Milne, Roger L.
    Gaudet, Mia
    Schmidt, Marjanka K.
    Broeks, Annegien
    Cox, Angela
    Fasching, Peter A.
    Hein, Rebecca
    Spurdle, Amanda B.
    Blows, Fiona
    Driver, Kristy
    Flesch-Janys, Dieter
    Heinz, Judith
    Sinn, Peter
    Vrieling, Alina
    Heikkinen, Tuomas
    Aittomaeki, Kristiina
    Heikkilae, Paeivi
    Blomqvist, Carl
    Lissowska, Jolanta
    Peplonska, Beata
    Chanock, Stephen
    Figueroa, Jonine
    Brinton, Louise
    Hall, Per
    Czene, Kamila
    Humphreys, Keith
    Darabi, Hatef
    Liu, Jianjun
    Van 't Veer, Laura J.
    Van Leeuwen, Flora E.
    Andrulis, Irene L.
    Glendon, Gord
    Knight, Julia A.
    Mulligan, Anna Marie
    O'Malley, Frances P.
    Weerasooriya, Nayana
    John, Esther M.
    Beckmann, Matthias W.
    Hartmann, Arndt
    Weihbrecht, Sebastian B.
    Wachter, David L.
    Jud, Sebastian M. S.
    Loehberg, Christian R.
    Baglietto, Laura
    English, Dallas R.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (03): : 250 - 263